Line separator


Black women face racial disparities in breast cancer screening

Researchers from University of Illinois Chicago recently conducted a study to discover if breast cancer-specific mortality among women with estrogen receptor-positive, axillary node-negative breast cancer differs by race within risk categories defined by the Oncotype Recurrence Score (RS).

The Oncotype RS is a genomic test that analyses the activity of a group of genes that can affect how a cancer is likely to behave and respond to treatment.

Dr Kent Hoskins, associate professor in the UIC College of Medicine’s division of hematology/oncology, and co-leader of the Breast Cancer Research group in the University of Illinois Cancer Center said: “Using data from the national SEER registry that included more than 70,000 patients across the U.S., we found there was a much higher mortality rate for African American women with the most common subtype of breast cancer event when they are diagnosed at an early stage.”

Read More